{"id":"W2520417021","doi":"10.1160/th16-06-0487","title":"Spotlight on unmet needs in stroke prevention: The PIONEER AF-PCI, NAVIGATE ESUS and GALILEO trials","year":2016,"lang":"en","type":"article","venue":"Thrombosis and Haemostasis","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"Bayer","keywords":"Rivaroxaban; Medicine; Vitamin K antagonist; Stroke (engine); Atrial fibrillation; Clopidogrel; Aspirin; Apixaban; Randomized controlled trial; Clinical trial; Antithrombotic; Intensive care medicine; Dabigatran; Internal medicine; Warfarin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06427415,0.001336741,0.007563649,0.001589258,0.0009612266,0.006994264,0.002210912,0.005947761,0.01283401],"category_scores_gemma":[0.0748984,0.0006955091,0.006635268,0.003178511,0.002405001,0.005776885,0.003928854,0.008162218,0.002310926],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002240123,"about_ca_system_score_gemma":0.005991261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002116487,"about_ca_topic_score_gemma":0.006342049,"domain_scores_codex":[0.9602711,0.02965598,0.0036819,0.001314572,0.003996396,0.001080027],"domain_scores_gemma":[0.8896321,0.07903073,0.01185623,0.0037106,0.007522301,0.008248036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04331417,0.0005691504,0.004500794,0.09106059,0.01586913,0.0002013664,0.0007843916,0.0007116362,0.001196912,0.02474498,0.3351386,0.4819084],"study_design_scores_gemma":[0.0766542,0.008396555,0.02315792,0.1242328,0.02356669,0.0005903236,0.0009783146,0.0007875426,0.0005470405,0.05566107,0.6850668,0.0003608707],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00450816,0.8453466,0.0006813593,0.1348921,0.006365761,0.0003911789,0.002186023,0.00007450458,0.005554285],"genre_scores_gemma":[0.0863045,0.6630071,0.0113169,0.1885423,0.03465951,0.00346831,0.008563587,0.0003783227,0.003759566],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.06427415,"threshold_uncertainty_score":0.3399183,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2244291703762564,"score_gpt":0.4140173523774548,"score_spread":0.1895881820011984,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}